Enzo Biochem (ENZ) News Today → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free ENZ Stock Alerts $1.07 +0.02 (+1.90%) (As of 12:07 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEnzo Biochem (NYSE:ENZ) and Biodesix (NASDAQ:BDSX) Financial Comparisonamericanbankingnews.com - April 27 at 1:16 AMBiodesix (NASDAQ:BDSX) vs. Enzo Biochem (NYSE:ENZ) Financial Reviewamericanbankingnews.com - April 26 at 1:40 AMIn Vitro Diagnostics Market Worth $119.4 billion | MarketsandMarketsfinanznachrichten.de - March 28 at 2:09 PMEnzo Biochem, Inc. (NYSE:ENZ) Sees Large Decrease in Short Interestmarketbeat.com - March 18 at 12:48 AMEnzo Biochem, Inc.: Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Updatefinanznachrichten.de - March 14 at 1:52 PMEnzo Biochem (NYSE:ENZ) shareholders have endured a 69% loss from investing in the stock three years agofinance.yahoo.com - March 14 at 1:52 PMEnzo Biochem: Fiscal Q2 Earnings Snapshotfinance.yahoo.com - March 13 at 8:01 PMEnzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Updateglobenewswire.com - March 13 at 4:26 PMEnzo Biochem, Inc. (NYSE:ENZ) Short Interest Updatemarketbeat.com - March 6 at 6:35 AMEnzo Biochem (NYSE:ENZ) Stock Passes Above Two Hundred Day Moving Average of $1.38marketbeat.com - February 17 at 3:31 AMEnzo Biochem, Inc.money.usnews.com - February 16 at 6:33 PMJim Simons Trims Stake in Enzo Biochem Incfinance.yahoo.com - February 14 at 6:26 AMEnzo Biochem Shareholders Elect Directors, Reject Exec Paymsn.com - February 2 at 12:17 PMEnzo Biochem Appoints New CEO and CFOmsn.com - February 2 at 12:17 PMEnzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointmentsfinance.yahoo.com - February 1 at 9:33 AMHere’s Why Laughing Water Capital Sold Enzo Biochem Inc (ENZ)finance.yahoo.com - January 30 at 8:15 AMENZ Stock Earnings: Enzo Biochem Reported Results for Q1 2024investorplace.com - December 16 at 12:01 AMENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATEfinance.yahoo.com - December 15 at 8:38 PMEnzo Biochem Inc (EZB.SG)finance.yahoo.com - December 14 at 6:09 PMImmunoassay Market is Expected to Reach $46.7 Billion | MarketsandMarkets.finance.yahoo.com - December 13 at 9:56 AMEnzo Biochem Inc ENZmorningstar.com - November 19 at 12:41 AMGlobal Oxidative Stress Assays Market to Reach $1.9 Billion by 2030: Players Include Cell Biolabs, Enzo Biochem, Merck and MilliporeSigmafinance.yahoo.com - November 8 at 9:19 AMSteven J. Pully Appointed to Enzo Biochem’s Board of Directorsfinance.yahoo.com - October 30 at 6:44 PMPoint of Care Molecular Diagnostics Market Worth $5.38 Billion by 2028 - Exclusive Report by The Insight Partnersbenzinga.com - October 30 at 8:08 AMEnzo Biochem: Cleaned Up And Cash-Rich But Unlovedmsn.com - October 26 at 8:44 AMEsoteric Testing Market to grow by USD 18.87 billion from 2022-2027, North America to account for 36% of market growth - Technaviofinance.yahoo.com - October 23 at 5:38 PMEnzo Biochem (NYSE:ENZ) shareholders have endured a 63% loss from investing in the stock five years agofinance.yahoo.com - October 6 at 2:20 PMNeurological Biomarkers Market to grow by USD 6.92 billion from 2022 to 2027 | North America to account for 43% of market growth- Technaviofinance.yahoo.com - September 18 at 10:41 AMNeuroscience Antibodies and Assays Market to grow by USD 1.83 billion from 2022 to 2027, North America to account for 46% of market growth- Technaviofinance.yahoo.com - September 11 at 5:12 AMEnzo Biochem CEO Hamid Erfanian Resigns After Two Yearsmarketwatch.com - September 6 at 9:20 AMEnzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEOfinance.yahoo.com - September 6 at 9:20 AMEnzo Biochem (NYSE: ENZ)fool.com - August 25 at 6:14 PMHere’s Why Laughing Water Capital Made a Position in Enzo Biochem (ENZ)finance.yahoo.com - July 31 at 11:09 AMEnzo Biochem, Inc.: Enzo Biochem Completes Sale of Clinical Laboratory to Labcorpfinanznachrichten.de - July 25 at 7:20 AMEnzo Biochem cuts price for labs assets to Labcorpseekingalpha.com - July 11 at 8:40 AMShort Volatility Alert: Enzo Biochem Incbenzinga.com - June 22 at 3:05 PMEnzo Biochem, Inc.: Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Resultsfinanznachrichten.de - June 15 at 7:35 AMEnzo Biochem reports Q3 resultsmsn.com - June 15 at 7:35 AMEmerson Firm Investigates Enzo Biochem Data Breachbenzinga.com - June 14 at 8:02 PMEnzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Resultsfinance.yahoo.com - June 14 at 8:02 PMEnzo Biochem, Inc.'s (NYSE:ENZ) Popularity With Investors Is Under Threat From Overpricingfinance.yahoo.com - June 8 at 11:56 AMEnzo Biochem says ransomware attack exposed clinical test data of 2.5 million patientsyahoo.com - June 1 at 8:42 AMEnzo Biochem says ransomware attack exposed patient info, Social Security numbersseekingalpha.com - May 31 at 2:41 AMEnzo Biochem, Inc.: Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Salefinanznachrichten.de - May 22 at 11:58 AMEnzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Salefinance.yahoo.com - May 22 at 11:58 AMEnzo Biochem Insiders Added US$11m Of Stock To Their Holdings \finance.yahoo.com - May 14 at 12:52 PMNon-Alcoholic Steatohepatitis (NASH) Drugs Market Growth Forecast 2023-2031 with Size and Sharemarketwatch.com - May 13 at 12:04 AMGlobal Blood Screening Market by [2023-2029] with Revenue Outsourcingmarketwatch.com - May 4 at 1:05 AMWound Healing Assay Kits Market Analysis and Forecast to 2031marketwatch.com - May 3 at 10:03 AMSHAREHOLDER ALERT: Weiss Law Investigates Enzo Biochem, Inc.benzinga.com - May 3 at 12:44 AM Get Enzo Biochem News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Healthcare Takes A Big Step Forward With The Help Of AI (Ad)The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+. Click here to see why this small company is trusted by the Mayo Clinic ENZ Media Mentions By Week ENZ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENZ News Sentiment▼0.240.34▲Average Medical News Sentiment ENZ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENZ Articles This Week▼20▲ENZ Articles Average Week Get Enzo Biochem News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Genetron News Today ProPhase Labs News Today CollPlant Biotechnologies News Today IceCure Medical News Today Gemini Therapeutics News Today Viveon Health Acquisition News Today SEP Acquisition News Today Checkpoint Therapeutics News Today HCW Biologics News Today Kezar Life Sciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ENZ) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzo Biochem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.